We are live on ! Find out more
BCPC

Balchem Corp

171.74 USD
-3.73
2.13%
At close Updated Sep 3, 4:00 PM EDT
Pre-market
After hours
172.00
+0.26
0.15%
1 day
-2.13%
5 days
-4.04%
1 month
-1.05%
3 months
9.65%
6 months
-5.31%
Year to date
11.5%
1 year
7.06%
5 years
22.04%
10 years
146.75%
 

About: Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

Employees: 1,379

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 42.9%
Neutral 57.1%
Negative 0%
Positive
Seeking Alpha
1 month ago
Balchem: It's A Buy From Me After Posting Strong Q2 Results
Balchem Corporation posted Q2 results, with EPS of $1.49 beating estimates by $0.07, while surpassing the consensus by $15M and was up 11% YoY. All areas of the business posted impressive results, as the minimum revenue growth for a segment was 8.9%, while the peak was 15% in Animal Nutrition & Health. The stock appears to be trading for a ~9% discount to its fair value right now based on my FCF valuation model.
Balchem: It's A Buy From Me After Posting Strong Q2 Results
Neutral
Seeking Alpha
1 month ago
Balchem Corporation (BCPC) Q2 2026 Earnings Call Transcript
Balchem Corporation (BCPC) Q2 2026 Earnings Call Transcript
Balchem Corporation (BCPC) Q2 2026 Earnings Call Transcript
Positive
Seeking Alpha
1 month ago
Conestoga SMid Cap Composite Q2 2026 Portfolio Review
West Pharmaceuticals stock moved higher following another quarter of broad-based growth, driven by continued demand for high-value biologics packaging and proprietary delivery components. Tyler Technologies underperformed during the quarter despite delivering solid financial results that met management's guidance. We were attracted to Knowles' accelerating organic growth, expanding margins, and exposure to several attractive long-term secular trends.
Conestoga SMid Cap Composite Q2 2026 Portfolio Review
Neutral
GlobeNewsWire
1 month ago
Balchem Corporation Reports Second Quarter 2026 Financial Results
MONTVALE, N.J., July 31, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today reported financial results for its 2026 fiscal second quarter ended June 30, 2026.
Balchem Corporation Reports Second Quarter 2026 Financial Results
Positive
Seeking Alpha
1 month ago
Conestoga Small Cap Composite Q2 2026 Portfolio Activity
DGII stock moved higher after the company reported record revenue and continued progress shifting toward a more recurring revenue-oriented business model. We remain encouraged by DSGX's mission-critical software, highly recurring revenue model, and disciplined capital allocation strategy, which continue to support our long-term investment thesis. We believe Kodiak Gas Services is well positioned to benefit from growing demand for natural gas infrastructure, LNG exports, and power generation supporting AI-related data center development.
Conestoga Small Cap Composite Q2 2026 Portfolio Activity
Neutral
GlobeNewsWire
1 month ago
Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2026 Financial Results on July 31, 2026
MONTVALE, N.J., July 17, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, July 31, 2026, at 11:00 AM Eastern Time (ET) to review second quarter results.
Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2026 Financial Results on July 31, 2026
Neutral
GlobeNewsWire
2 months ago
Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026
MONTVALE, N.J., June 26, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026.
Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026
Neutral
GlobeNewsWire
3 months ago
Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026
MONTVALE, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the Wells Fargo Industrials Conference on June 10, 2026.
Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026
Positive
Seeking Alpha
3 months ago
My Top Dividend Growth Picks In Each GICS Sector
I present my top dividend growth picks for each of the 11 GICS sectors, emphasizing discounted valuations and safe, growing dividends. The Sector Winners portfolio outperformed SPY with a 333% five-year return (ex-dividends) and a 0.9% yield; Runners-Up returned 83% with a 1.3% yield. I use a rigorous quality scoring system and sector diversification to minimize dividend cut risks and optimize portfolio resilience.
My Top Dividend Growth Picks In Each GICS Sector
Neutral
Seeking Alpha
4 months ago
Balchem Corporation (BCPC) Q1 2026 Earnings Call Transcript
Balchem Corporation (BCPC) Q1 2026 Earnings Call Transcript
Balchem Corporation (BCPC) Q1 2026 Earnings Call Transcript
Price charts implemented using Lightweight Charts™